Alterations in the Th1/Th2 balance in breast cancer patients using reflexology and scalp massage

Experimental and Therapeutic Medicine

Volumn 1, Issue 1, 2010, Pages 97-108

  Green, Victoria L ^a   Alexandropoulou, Afroditi ^a   Walker, Mary B ^a   Walker, Andrew A ^a   Sharp, Donald M ^a   Walker, Leslie G ^a   Greenman, John ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Breast cancer; Complementary and alternative therapies; Immune response; Neuroendocrine; Stress

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON; GROWTH HORMONE; HYDROCORTISONE; PROLACTIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CD25+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; ENDOCRINE FUNCTION; FEMALE; FLOW CYTOMETRY; GROWTH HORMONE BLOOD LEVEL; HOST RESISTANCE; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MASSAGE; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REFLEXOLOGY; TH1 CELL; TH2 CELL;

EID: 77955766846     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm_00000018     Document Type: Article

References (68)

1. Cancer Research UK: News and Resources (http://info.cancerresearchuk.org/cancerstats/types/breast/incidence).
2. Zabora J, Brintzenhofenszoc K, Curbow B, Hooker C and Piantadosi S: The prevalence of psychological distress by cancer site. Psychooncology 10: 19-28, 2001.
3. Hall A, A'Hern R and Fallowfield L: Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? Eur J Cancer 35: 79-85, 1999.
4. Burgess C, Cornelius V, Love S, Graham J, Richards M and Ramirez A: Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 330: 702, 2005.
5. Cassileth BR and Vickers AJ: High prevalence of complementary therapy and alternative medicine use among cancer patients. J Clin Oncol 23: 2590-2592, 2005.
6. Molassiotis A, Fernadez-Ortega P, Pud D, et al: Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16: 655-663, 2005.
7. Ernst AR and White A: The BBC survey of complementary medicine use in the UK. Complement Ther Med 8: 32-36, 2000.
8. Matthews AK, Sellergren MA, Huo D, List M and Fleming G: Complementary and alternative medicine use among breast cancer survivors. J Altern Complement Med 13: 555-562, 2007.
9. Corner J, Cawley N and Hildebrand S: An evaluation of the use of massage and essential oils on the wellbeing of cancer patients. Int J Palliat Nurs 1: 67-73, 1995.
10. Elenkov IJ and Chrousos GP: Stress system - Organization, physiology and immunoregulation. Neuroimmunomodulation 13: 257-267, 2006.
11. Walker LG, Green VL, Greenman J, Walker A and Sharp DM: PNI and Chronic Malignant Disease: Cancer. In: Human Psychoneuroimmunology (PNI). Irwin M and Vedhara K (eds). Oxford University Press, UK, pp 137-163, 2005.
12. Herbert TB and Cohen S: Stress and immunity in humans: a meta-analytic review. Psychosom Med 55: 364-379, 1993.
13. Segerstrom SC and Miller GE: Psychological stress and the immune system: a meta-analytic study of 30 years of enquiry. Psychol Bull 130: 601-630, 2004.
14. Ghiringhelli F, Menard C, Puig PE, et al: Metronomic cyclophos-phamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunol Immunother 56: 641-648, 2007.
15. Spiegel D and Giese-Davis J: Depression and cancer: mechanisms and disease progression. Biol Psychiatry 54: 269-282, 2003.
16. Yang EV and Glaser R: Stress-induced immunomodulation: implications for tumorigenesis. Brain Behav Immun 17 (Suppl1): 37-40, 2003.
17. Penninx BW, Guralnik JM, Pahor M, Ferrucci L, Cerhan JR, Wallace RB and Havlik RJ: Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst 90: 1888-1893, 1998.
18. Ikeda H, Old LJ and Schreiber RD: The roles of IFNγ in protection against tumour development and cancer immunoediting. Cytokine Growth Factor Rev 13: 95-109, 2002.
19. Nelson EL, Wenzel LB, Osann K, et al: Stress, immunity and cervical cancer: biobehavioural outcomes of a randomized clinical trial. Clin Cancer Res 14: 2111-2118, 2008.
20. Neuner A, Schindel M, Wildenberg U, Muley T, Lahm H and Fischer JR: Prognostic significance of cytokine modulation in non-small cell lung cancer. Int J Cancer 101: 2872-2892, 2002.
21. O'Hara RJ, Greenman J, MacDonald AW, et al: Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production. Clin Cancer Res 4: 1943-1948, 1998.
22. Webster Marketon JI and Glaser R: Stress hormones and immune function. Cell Immunol 252: 16-26, 2008.
23. Lightman SL: The neuroendocrinology of stress: a never ending story. J Neuroendocrinol 20: 880-884, 2008.
24. Dohi K, Kraemer WJ and Mastro AM: Exercise increases prolactin-receptor expression on human lymphocytes. J Appl Physiol 94: 518-524, 2003.
25. Gotovac K, Sabioncello A, Rabatic S, Berki T and Dekaris D: Flow cytometric determination of glucocorticoid receptor (GCR) expression in lymphocyte subpopulations: lower quantity of GCR in patients with post-traumatic stress disorder (PTSD). Clin Exp Immunol 131: 335-339, 2003.
26. Rapaport R, Sills IN, Green L, et al: Detection of human growth hormone receptors on IM-9 cells and peripheral blood mononuclear cell subsets by flow cytometry: correlation with growth hormone-binding protein levels. J Clin Endocrinol Metab 80: 2612-2619, 1995.
27. Malarkey WB and Mills PJ: Endocrinology: the active partner in PNI research. Brain Behav Immun 21: 161-168, 2007.
28. Besedovsky HO and Rey AD: Physiology of psychoneuroimmunology: a personal view. Brain Behav Immun 21: 34-44, 2007.
29. Leonard BE: The HPA and immune axes in stress: the involvement of the serotonergic system. Eur Psychiatry 20 (Suppl 3): 302-306, 2005.
30. Ross K: Mapping pathways from stress to cancer progression. J Natl Cancer Inst 100: 914-917, 2008.
31. Facchinetti F, Tarabusi M and Volpe A: Cognitive-behavioral treatment decreases cardiovascular and neuroendocrine reaction to stress in women waiting for assisted reproduction. Psychoneuroendocrinology 29: 162-173, 2004.
32. Gaab J, Blattler N, Menzi T, Pabst B, Stoyer S and Ehlert U: Randomized controlled evaluation of the effects of cognitive-behavioral stress management on cortisol responses to acute stress in healthy subjects. Psychoneuroendocrinology 28: 767-779, 2003.
33. McKinney CH, Antoni MH, Kumar M, Tims FC and McCabePM: Effects of guided imagery and music (GIM) therapy on mood and cortisol in healthy adults. Health Psychol 16: 390-400, 1997.
34. Cruess DG, Antoni MH, McGregor BA, et al: Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer. Psychosom Med 62: 304-308, 2000.
35. Turner-Cobb JM, Sephton SE, Koopman C, Blake-Mortimer J and Spiegel D: Social support and salivary cortisol in women with metastatic breast cancer. Psychosom Med 62: 337-345, 2000.
36. Van der Pompe G, Duivenvoorden HJ, Antoni MH, Visser A and Heijnen CJ: Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients: an exploratory study. J Psychosom Res 42: 453-466, 1997.
37. Heinrichs M, Baumgartner T, Kirschbaum C and Ehlert U: Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry 54: 1389-1398, 2003.
38. Eremin O, Walker MB, Simpson E, et al: Immuno-modulatory effects of relaxation training and guided imagery in women with locally advanced breast carcinoma undergoing multimodality treatment. Breast 18: 17-25, 2008.
39. Andersen BL, Farrar WB, Golden-Kreutz DM, et al: Psychological, behavioral and immune changes after a psychological intervention: a clinical trial. J Clin Oncol 22: 3570-3580, 2004.
40. McGregor BA, Antoni MH, Boyers A, Alferi SM, BlombergBB and Carver CS: Cognitive-behavioural stress management increases benefit finding and immune function among women with early stage breast cancer. J Psychosom Res 56: 1-8, 2004.
41. Hernandez-Reif M, Ironson G, Field T, et al: Breast cancer patients have improved immune and neuroendocrine functions following massage therapy. J Psychosom Res 57: 45-52, 2004.
42. Walker LG, Walker MB, Ogston K, et al: The psychological, clinical and pathological effects of relaxation training and imagery during primary chemotherapy. Br J Cancer 80: 262-268, 1999.
43. Fawzy FI, Kemeny ME, Fawzy NW, Elashoff R, Morton D, Cousins N and Fahey JL: A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures. Arch Gen Psychiatry 47: 729-735, 1990.
44. Walker LG: Psychosocial Oncology in Hull and the East Riding of Yorkshire. Newsletter of the British Psychosocial Oncology Society, March: 10-12, 2000.
45. Anderson BL: Psychological interventions for cancer patients to enhance quality of life. J Consult Clin Psychol 60: 552-568, 1992.
46. Boyum A: Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran and ficoll as erythrocyteaggregating agents. Scand J Clin Lab Invest 97: 31-50, 1968.
47. Jung T, Schauer U, Heusser C, Neuman C and Rieger C: Detection of intracellular cytokines by flow cytometry. J Immunol Methods 159: 197-207, 1993.
48. Piriou L, Chilmonczyk S, Genetet N and Albina E: Design of a flow cytometric assay for the determination of natural killer and cytotoxic T-lymphocyte activity in human and in different animal species. Cytometry 41: 289-297, 2000.
49. Carlens S, Gilljam M, Chambers BJ, et al: A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells. Hum Immunol 62: 1092-1098, 2001.
50. Vickers AJ and Altman DG: Statistics notes: analysing controlled trials with baseline and follow-up measurements. BMJ 323: 1123-1124, 2001.
51. Carlson LE, Speca M, Patel KD and Goodey E: Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med 65: 571-581, 2003.
52. Wilkinson SM, Love SB, Westcombe AM, et al: Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: a multicentre randomized controlled trial. J Clin Oncol 25: 532-539, 2007.
53. Kuss I, Hathaway B, Ferris RL, Gooding W and Whiteside TL: Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease. Adv Otorhinolaryngol 62: 161-172, 2005.
54. Hong WS, Min Y, Son YS and Hong S: Peripheral blood lymphocyte subsets in patients with stomach cancer. J Korean Med Sci 10: 164-168, 1995.
55. Heys SD, Gough DB and Eremin O: Immunotherapy with interleukin-2, recent developments. Expert Opin Investig Drugs 5: 269-288, 1996.
56. Al Sarireh B and Eremin O: Tumour associated macrophage (TAMTAMS): disordered function, immune suppression and progressive tumour growth. J R Coll Surg Edinb 45: 1-16, 2000.
57. Beyer M and Schultze JL: Regulatory T cells in cancer. Blood 108: 804-811, 2006.
58. Curiel TJ: Tregs and rethinking cancer immunotherapy. J Clin Invest 117: 1167-1174, 2007.
59. Trzonkowski P, Szmit E, Myśliwska J and Myśliwski A: CD4+CD25+ T regulatory cells inhibit cytotoxic acitivity of CTL and NK cells in humans - impact of immunosenescence. Clin Immunol 119: 307-316, 2006.
60. Hernandez-Reif M and Field T: Natural killer cells and lymphocytes increase in women with breast cancer following massage therapy. Int J Neurosci 115: 495-510, 2005.
61. Bakke AC, Purtzer MZ and Newton P: The effect of hypnotic-guided imagery on psychological well-being and immune function in patients with prior breast cancer. J Psychosom Res 53: 1131-1137, 2002.
62. Brittenden J, Heys SD, Ross J and Eremin O: Natural killer cells and cancer. Cancer 77: 1226-1243, 1996.
63. Malmberg KJ, Bryceson YT, Carlsten M, et al: NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy. Cancer Immunol Immunother 57: 1541-1552, 2008.
64. Joshi AD, Clark EM, Wang P, et al: Immunotherapy of human neuroblastoma using umbilical cord blood-derived effector cells. J Neuroimmune Pharmacol 2: 202-212, 2007.
65. Godoy-Ramirez K, Franck K and Gaines H: A novel method for the simultaneous assessment of natural killer cell conjugate formation and cytotoxicity at the single-cell level by multi-parameter flow cytometry. J Immunol Methods 239: 35-44, 2000.
66. Glaser R, Maccallum RC, Laskowski BF, Malarkey WB, Sheridan JF and Kiecolt-Glaser JK: Evidence for a shift in the Th-1 to Th-2 cytokine response associated with chronic stress and ageing. J Gerontol A Biol Sci Med Sci 56: 477-482, 2001.
67. Carlson LE, Speca M, Patel KD and Goodey E: Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology 29: 448-474, 2004.
68. Walker AA, Walker MB, Greenman J, Sharp DM and Walker LG: Does reflexology improve quality of life in women who have undergone surgery for early breast carcinoma? Psychooncology 15: S137, 2006.